High-quality medicines for changing needs
In response to the ever-changing needs of the people we serve, we are broadening the range of medicines we offer for chronic therapeutic categories such as central nervous system, cardiovascular, diabetes and oncology. Currently, we supply over 350 branded generic medicines in the MENA and emerging markets. Globally, we provide over 500 generic injectable medicines.
Related news
Hikma establishes partnership with Melinta in MENA
28 February 2019
Hikma has launched Ritonavir Tablets USP
20 March 2018